Scientists have discovered a potential new way to treat one of the most aggressive blood cancers, offering hope to thousands of patients.
A study from the University of Cambridge, published in the journal Nature Biotechnology, has found that a common protein behaves unexpectedly in leukaemia cells, a discovery that could lead to more effective treatments for Acute Myeloid Leukaemia (AML).
This collaborative study was co-first authored by Dr Benson George,
